סינולוקס lc וטרינרי
pfizer pharmaceuticals israel ltd - amoxicillin as trihydrate 200 mg/dose; clavulanic acid as potassium 55 mg/dose - suspension for injection - combinations - for the treatment of bovine mastitis in lactating cows. it has a broad spectrum of bactericidal activity against bacteria which are sensitive to synulox isolated from the bovine udder.
אוגמנטין תרחיף 125 מ"ג/5 מ"ל
glaxo smith kline (israel) ltd - amoxicillin as trihydrate 125 mg / 5 ml; clavulanic acid as potassium 31.25 mg / 5 ml - suspension - ampicillin and enzyme inhibitor - fot the treatment of lower respiratory tract infections, otitis media infections, sinusitis infections, acute pharyngitis, skin and soft tissues infections and urinary tract infections caused also by beta-lactamase producing organisms which are susceptible to augmentin and are resistant to other beta-lactam antibiotics.
סולבסול להזרקה וטרינרי
comex ltd - cefalexin as sodium 180 mg/ml - suspension for injection - cefalexin - for the treatment of infections caused by or associated with microorganisms sensitive to cephalexin in cattle and dogs.
זינט תרחיף 125 מג5 מל
novartis israel ltd., israel - cefuroxime as axetil - suspension - cefuroxime as axetil 25 mg/ml - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible microorganisms.
זינט תרחיף 250 מג5 מל
novartis israel ltd., israel - cefuroxime as axetil - suspension - cefuroxime as axetil 50 mg/ml ml - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible micro-organism.
אקטסל
medici ltd - diphtheria toxoid 15 lf / 0.5 ml; filamentous haemogglutinin (fha) 5 mcg / 0.5 ml - suspension for injection - hemophilus influenzae b, combinations with pertussis and toxoids - primary vaccination of infants, at or above the age of two months and as a booster in children up to their 6th birthday against diphtheria, tetanus, pertussis and invasive haemophilus influenzae type b infection.
פוליאסל
medici ltd - diphtheria toxoid 15 lf / 0.5 ml; filamentous haemogglutinin (fha) 20 mcg / 0.5 ml - suspension for injection - hemophilus influenzae b, combinations with pertussis and toxoids - primary vaccination of infants, at or above the age of two months and as a booster in children up to their 6th birthday against diphtheria, tetanus, pertussis, poliomyelitis and invasive haemophilus influenzae type b infections.
וקסיגריפ לילדים
medici ltd - a/california/7/2009 (h1n1) 7.5 mcg/dose; a/victoria/361/2011 (h3n2) 7.5 mcg/dose - suspension for injection - influenza, inactivated, whole virus - for the prevention of influenza, particularly in children aged from 6 to 35 months who run an increased risk of associated complications.
פוסטריה
neopharm scientific ltd - a/california/7/2009 (h1n1) 7.5 mcg / 0.5 ml - suspension for injection - influenza, inactivated, whole virus - prophylaxis of influenza in an officially declared pandemic situation.pandemic influenza vaccine should be used in accordance with official guidance.
פוסטריה
neopharm scientific ltd - a/california/7/2009 (h1n1) 7.5 mcg / 0.5 ml - suspension for injection - influenza, inactivated, whole virus - prophylaxis of influenza in an officially declared pandemic situation.pandemic influenza vaccine should be used in accordance with official guidance.